Skip to main content

TMAU2 and the 'schizophrenia' of the intestinal tract

Several TMAU2 positive tested people reported that their body odor symptoms increased strongly in stress related situations.

As we now have included the noradrenaline and adrenaline degradation path, the metabolism map shows a high impact in both pathways.

If a enzyme defect around the BHMT enzyme is assumed, the result would be that the intestinal tract runs very fast out of SAM (S-adenosyl-methionine).

Low SAM levels would of course be further drained by the release of noradrenalin and adrenaline.

In both degradation pathes the COMT enzyme is responsible for the further drain of SAM.

RNA expression of the COMT shows clearly that COMT is not only present in the brain, instead in the intestinal tract, liver, etc. as well.

The COMT enzyme was once the major target of schizophrenia research.

Today it seems that the body odor diseases are strongly related to enzymes which cause schizophrenia and depression.

The main difference is that those enzymes are in the body odor cases locally inhibited within the intestinal tract area.

Nevertheless is the relation so strong that it might be appropriate to name the body odor disease impacts as 'schizophrenia of the intestinal tract'.

Comments

Popular posts from this blog

Glutamine and Glutamate seems to increase butyrate production in the large intestinal tract

Glutamine and its counterpart glutamate seems to increase the butyrate production in the intestinal tract. Butyrates show a biting or pungeant, light sweat like smell. This strengthens the view that the tight junction sealing is dominated by metabolite pathways that present in one or the other way highly smelling chemical compounds the body is forced to absorb to counter regulate its deregulated energy metabolism in the intestinal tract .

Bromhidrosis TSH+: Diet protocol + nystatin, nigella sativa + h1 receptor antagonists + medicinal clay improves body odor condition

In our explorative case we were further able to improve the diet protocol as well as finding a new drug/supplement  composition. We are taking advantage of following over the counter drugs/supplements: - Nystatin - Nigella sativa (black cumin) capsules - H1 receptor antagonists (loratadin) - medicinal clay The diet protocol was taken from: https://drive.google.com/folderview?id=19hmatFJPil1svc9DRyuRn3S9rUF7yqH_ Dosages (daily) applied were like the following: nystatin: 6x pills (3x at morning, 3x at evening) nigella sativa: >10000mg (5x 400mg capsules before every meal, 5 meals per day) loratadin: 50mg - 100mg daily medicinal clay: 6x 6g (luvos healing earth)

Candida pathogenesis in Bromhidrosis

Our observation was that bromhidrosis patients reported slight elevated candida sp. levels in combination mit reduced enterococcus sp. in stool analysis results. The current metabolism impact for bromhidrosis seems to be sourced in a deficient acetate or propionate degrading enzyme which is part of the major ethanol degradation. The biosynthesis of ethanol is mostly based on candida sp., so we investigated into the pathogenesis of candida. The following pictures show the resulting disease model. In the case of an deficiency in the ethanol degradation pathway, the immune system shows a weakness regarding the candida sp., which shifts the microbiome towards increased candida occurence and activity. This would lead to small intestinal fungal overgrowth (SIFO) symptoms